Analyst firms · Guggenheim · ACET
Guggenheim ACET price target and rating history
Adicet Bio Inc. (ACET) · Health Care
Guggenheim rates Adicet Bio Inc. (ACET) Buy with a $7 price target, as of its latest action on Sep 30, 2024. It has published 3 rating actions on ACET since December 2021, including 0 upgrades and 1 downgrade.
- Current rating
- Buy
- Price target
- $7
- Median target, all firms
- Too few
- Actions on ACET
- 3
Guggenheim price target on ACET
Every Guggenheim rating on ACET
- Sep 30, 2024
- Jun 27, 2023
- Dec 6, 2021
Questions about Guggenheim and ACET
- What is Guggenheim's price target for ACET?
- Guggenheim's latest stated price target for Adicet Bio Inc. (ACET) is $7, from its action on Sep 30, 2024.
- What is Guggenheim's rating on ACET?
- Guggenheim rates ACET Buy, a bullish rating, as of Sep 30, 2024.
- When did Guggenheim last change its view on ACET?
- On Sep 30, 2024, Guggenheim resumes coverage at Buy, price target $7.
All Guggenheim ratingsACET news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.